About Dhanvanthri Super Speciality Private Limited
Data last updated:
Dhanvanthri Super Speciality Private Limited is a private limited company based in Bangalore, Karnataka, India. It was incorporated on 11 August 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U46497KA2023PTC177243. Its GSTIN is 29AAKCD2286Q1ZS (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhavya Balaraj (Whole-Time Director) and Guttahalli Krishnappa Shridhar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 32 Park, Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹126.02 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.59 Cr (net margin 2.8%) and EBITDA of ₹9.91 Cr (EBITDA margin 7.9%).
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹25 Cr on record.
For more details, the company can be reached via its website dhanvanthrispeciality.com.
Company details
Contact details
Dhanvanthri Super Speciality Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo. 32 Park Area, Wilson Garden, Bangalore, Karnataka, India – 560027
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dhanvanthri Super Speciality is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dhanvanthri Super Speciality Private Limited, buy the company report.
Financials of Dhanvanthri Super Speciality Private Limited
FY 2025 filings availableDhanvanthri Super Speciality Private Limited reported revenue of ₹126.02 Cr (up 318% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 318% in the latest year. EBITDA rose 236% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹9.91 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3.59 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 7.9% | |
| Net Profit Margin | 2.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Dhanvanthri Super Speciality Private Limited, buy the company report.
Board of directors of Dhanvanthri Super Speciality Private Limited
Dhanvanthri Super Speciality has 7 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sambit Mohanty | Director | 11 Dec 2023 | 2 Years 10 Months | Current |
| Satyendra Tiwari | Additional Director | 26 May 2025 | 1 Years 4 Months | Current |
| Bhavya Balaraj Also directs: Dhanvanthri Speciality Pharma Private Limited | Whole-Time Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Guttahalli Krishnappa Shridhar Also directs: Dhanvanthri Speciality Pharma Private Limited | Whole-Time Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Manish Kumar Also directs: Devi Pharma Wellness Private Limited, Sai Pharma Distributors Private Limited, Saurashtra Medisolutions Private Limited and 5 more | Additional Director | 26 May 2025 | 1 Years 4 Months | Current |
| Kushal Ashok Shah Also directs: Elation Advisory LLP | Additional Director | 30 Jun 2025 | 1 Years 3 Months | Current |
Peer comparison
Dhanvanthri Super Speciality Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aiocd Pharma Limited | ₹127.15 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Kyal Agencies Private Limited | ₹127.04 Cr (FY 2025) | 14.0% | Bhubaneswar, Odisha, India | |||
| Evolet Healthcare Private Limited | ₹126.91 Cr (FY 2025) | -5.0% | Bhorakalan, Haryana, India | |||
| Dhanvanthri Super Speciality Private Limitedthis company | ₹126.02 Cr (FY 2025) | ₹3.59 Cr | 2.8% | 318.0% | Bangalore, Karnataka, India | |
| Sysmed Exim Private Limited | ₹125.82 Cr (FY 2024) | -57.0% | Mohali, Punjab, India | |||
| Care Formulation Labs Private Limited | ₹125.33 Cr (FY 2025) | 19.0% | New Delhi, Delhi, India | |||
| Jaggi Enterprises Private Limited | ₹123.9 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India |
To see the full peer comparison of Dhanvanthri Super Speciality Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Nov 2024 | 101016440 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 19 Dec 2023 | 100845958 | Others | ₹25 Cr | Satisfied |
To see the full charge records of Dhanvanthri Super Speciality Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Dhanvanthri Super Speciality Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dhanvanthri Super Speciality Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dhanvanthri Super Speciality has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKCD2286Q1ZS | Karnataka | Active | 04 Nov 2023 |
To see the full GST registrations and return filing status of Dhanvanthri Super Speciality Private Limited, buy the company report.
Recent activity
Dhanvanthri Super Speciality Private Limited has 14 board changes on record since 2023: 8 appointments and 6 cessations. The latest: Kushal Ashok Shah was appointed as Additional Director on 30 Jun 2025.
8 earlier events are in the company report.
Frequently asked questions
Dhanvanthri Super Speciality is an active private limited company based in Bangalore, Karnataka, India. It was incorporated on 11 August 2023 (3+ years old) and is registered under CIN U46497KA2023PTC177243.
Dhanvanthri Super Speciality has 7 current directors:
- Bhavya Balaraj - Whole-Time Director
- Guttahalli Krishnappa Shridhar - Whole-Time Director
- Sambit Mohanty - Director
- Satyendra Tiwari - Additional Director
- Manish Kumar - Additional Director
- Kushal Ashok Shah - Additional Director
- Nikesh Kesarimal Oswal - Additional Director
The latest financial statements of Dhanvanthri Super Speciality on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Dhanvanthri Super Speciality is 29AAKCD2286Q1ZS, registered in Karnataka.
The CIN (Corporate Identification Number) of Dhanvanthri Super Speciality is U46497KA2023PTC177243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dhanvanthri Super Speciality was incorporated on 11 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Dhanvanthri Super Speciality by revenue are Aiocd Pharma Limited, Kyal Agencies Private Limited, Evolet Healthcare Private Limited, Sysmed Exim Private Limited, Care Formulation Labs Private Limited and 1 more, all in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kushal Ashok Shah was appointed as Additional Director on 30 Jun 2025. Nikesh Kesarimal Oswal was appointed as Additional Director on 30 Jun 2025. Manish Kumar was appointed as Additional Director on 26 May 2025. Dhanvanthri Super Speciality has 14 board changes on record in total.
Dhanvanthri Super Speciality can be reached through the website dhanvanthrispeciality.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Dhanvanthri Super Speciality is at No. 32 Park Area, Wilson Garden, Bangalore, Karnataka, India – 560027.
Dhanvanthri Super Speciality has open charges of ₹20 Cr and satisfied charges of ₹25 Cr as per latest MCA filings.